Mechanisms of Adverse Drug Effects in Children (R21)

The summary for the Mechanisms of Adverse Drug Effects in Children (R21) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Mechanisms of Adverse Drug Effects in Children (R21): - The major focus of the funding opportunity is to solicit projects that enhance the state-of-the-science on the molecular and cellular mechanisms involved in the production of adverse drug reactions in children.-Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary.-The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received.-This funding opportunity will utilize the exploratory/developmental (R21) grant mechanism and runs in parallel with an FOA of identical scientific scope (PA-05-045) that solicits applications under the traditional Research Project Grant (R01) award mechanism.-Eligible Organizations: For-profit and non-profit organizations; public or private institutions, such as universities, colleges, hospitals, and laboratories; units of State and local governments; eligible agencies of the Federal government; domestic or foreign institutions/organizations; faith-based or community-based organizations; Indian/Native American Tribal Government (Federally Recognized); Indian/Native American Tribal Government (Other than Federally Recognized); and Indian/Native American Tribally Designated Organization-Eligible Project Directors/Principal Investigators (PDs/PIs): Individuals with the skills, knowledge, and resources necessary to carry out the proposed research are invited to work with their institution to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support.